Role of volume-stimulated osmolyte and anion channels in volume regulation by mammalian sperm.
The ability to maintain cellular volume is an important general physiological function. Swelling induced by hypotonic stress results in the opening of channels, through which ions exit with accompanying water loss (regulatory volume decrease, RVD). RVD has been shown to occur in mammalian sperm, primarily through the opening of quinine-sensitive potassium channels. However, as yet, direct evidence for the participation of anion channels in sperm RVD has been lacking. The chloride channel type ClC-3 is believed to be involved in RVD in other cell types. Using electronic cell sizing for cell volume measurement, the following results were obtained. (i) The anion channel blockers 5-nitro-2-(3-phenylpropylamino)-benzoic acid (NPPB), tamoxifen and 4,4'-diisothiocyanostilbene-2,2'-disulphonic acid (DIDS) increased hypotonic swelling in concentration-dependent fashion, whereas verapamil (P-glycoprotein inhibitor) had little effect. The most potent, NPPB and DIDS, blocked RVD without affecting cell membrane integrity at effective concentrations. (ii) When gramicidin was included to dissipate Na+/K+ gradients, major secondary swelling was observed under hypotonic conditions. This secondary swelling could be reduced by NPPB, and suppressed completely by replacing chloride in the medium with sulphate, an ion which does not pass through chloride channels. It was deduced that the initial hypotonic swelling activated an anion channel through which chloride ions could then enter freely down a concentration gradient, owing to the lack of a counter-gradient of potassium. (iii) Taurine, an osmolyte often involved in RVD, does not appear to play a role in sperm RVD because lengthy preincubation with taurine did not alter sperm RVD response. Our observations provide direct evidence that a chloride channel (possibly ClC-3) is involved in the process of volume regulation in mammalian sperm.
Petrunkina
A M
AM
Institute of Reproductive Medicine, University of Veterinary Medicine Hannover, Foundation, Bünteweg 15, 30559 Hannover, Germany. anna.petrounkina@tiho-hannover.de
Harrison
R A P
RA
Ekhlasi-Hundrieser
M
M
Töpfer-Petersen
E
E
D017878:4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid / Q000494:pharmacology; D000818:Animals; D048429:Cell Size; D018118:Chloride Channels / Q000037:antagonists & inhibitors / Q000502:physiology*; D006096:Gramicidin / Q000494:pharmacology; D007038:Hypotonic Solutions / Q000494:pharmacology; D008297:Male; D009579:Nitrobenzoates / Q000494:pharmacology; D009997:Osmotic Pressure / Q000187:drug effects; D013094:Spermatozoa / Q000166:cytology* / Q000187:drug effects / Q000502:physiology*; D034421:Sus scrofa; D013629:Tamoxifen / Q000494:pharmacology; D013654:Taurine / Q000494:pharmacology; D014700:Verapamil / Q000494:pharmacology
D018118:Chloride Channels; C115376:ClC-3 channel; D007038:Hypotonic Solutions; D009579:Nitrobenzoates; D013629:Tamoxifen; D006096:Gramicidin; D013654:Taurine; C058176:5-nitro-2-(3-phenylpropylamino)benzoic acid; D014700:Verapamil; D017878:4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid